Discovery and mechanistic characterization of a probiotic‐origin 3β‐ OH ‐Δ 5‐6 ‐cholesterol‐5β‐reductase directly converting cholesterol to coprostanol
The FEBS Journal · 2025
DOI: 10.1111/febs.70131 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Urmila Netter und 12 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Biology Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology, Roorkee, India. Hauptthemen laut MEDLINE: Cholesterol, Probiotics, Limosilactobacillus fermentum, Cholestanol. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India, Council of Scientific and Industrial Research (CSIR), India.
Abstract (Originalsprache)
Cholesterol serves as a fundamental molecule in various structural and biochemical pathways; however, high cholesterol levels are linked to cardiovascular diseases. Some selected strains of Lactobacilli are known for modulating cholesterol levels. However, the molecular mechanism underlying cholesterol transformation by lactobacilli has remained elusive. This study describes the discovery and function of a microbial 3β‐OH‐Δ 5‐6 ‐cholesterol‐5β‐reductase (5βChR) from Limosilactobacillus fermentum NKN51, which directly converts cholesterol to coprostanol, thereby unraveling this longstanding mystery. Protein engineering of the reductase enzyme identified the cholesterol and NADPH interacting amino acid residues, detailing the catalytic mechanism of 5βChR. Phylogenetic analyses highlight the prevalence of 5βChRs in gut commensal lactobacilli, which share a common evolutionary origin with plant 5β reductases. Meta‐analysis of microbiomes from healthy individuals underscores the importance of 5βChR homologs, while a cohort study demonstrates an inverse association between 5βChR abundance and diabetes. The discovery of the 5βChR enzyme and its molecular mechanism in cholesterol metabolism paves the way for a better understanding of the gut‐associated microbiome and the design of practical applications to ameliorate dyslipidemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemical Biology Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology, Roorkee, India.
- Proteomics and Lipidomics Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology, Roorkee, India.
- Centralized Core Research Facility, All India Institute of Medical Sciences, New Delhi, India.
- Stem Cell Facility (DBT-Centre of Excellence for Stem Cell Research), All India Institute of Medical Sciences, New Delhi, India.
- ICAR-National Research Centre on Yak, Dirang, India.
- Department of Biology, Memorial University of Newfoundland and Labrador, St. John's, Canada.
ORCID-Profile: Kiran Ambatipudi, Naveen K Navani
Förderung
- Department of Biotechnology, Ministry of Science and Technology, India
- Council of Scientific and Industrial Research (CSIR), India
Zitieren
APA
Netter, U., Bisht, V., Gaurav, A., Sharma, R., Ghosh, A., Bisht, V. S., Ambatipudi, K., Sharma, H. P., Mohanty, S., Loat, S., Sarkar, M., Tahlan, K., & Navani, N. K. (2025). Discovery and mechanistic characterization of a probiotic‐origin 3β‐ OH ‐Δ 5‐6 ‐cholesterol‐5β‐reductase directly converting cholesterol to coprostanol. The FEBS Journal. https://doi.org/10.1111/febs.70131
Vancouver
Netter U, Bisht V, Gaurav A, Sharma R, Ghosh A, Bisht VS, et al. Discovery and mechanistic characterization of a probiotic‐origin 3β‐ OH ‐Δ 5‐6 ‐cholesterol‐5β‐reductase directly converting cholesterol to coprostanol. The FEBS Journal. 2025. doi:10.1111/febs.70131
BibTeX
@article{Netter2025,
author = {Netter, Urmila and Bisht, Vishakha and Gaurav, Amit and Sharma, Rekha and Ghosh, Avik and Bisht, Vinod Singh and Ambatipudi, Kiran and Sharma, Hanuman Prasad and Mohanty, Sujata and Loat, Shubham and Sarkar, Mihir and Tahlan, Kapil and Navani, Naveen K},
title = {Discovery and mechanistic characterization of a probiotic‐origin 3β‐ OH ‐Δ 5‐6 ‐cholesterol‐5β‐reductase directly converting cholesterol to coprostanol},
journal = {The FEBS Journal},
year = {2025},
doi = {10.1111/febs.70131}
}
EUVIMED